Navigation Links
NW Bio's Patent Portfolio Further Expanded With Manufacturing Automation Patent
Date:9/10/2013

nt Phase III trial in newly diagnosed Glioblastoma multiforme (GBM). GBM is the most aggressive and lethal brain cancer.  The Company also previously received clearance from the FDA for a 612-patient Phase III trial in prostate cancer, and clearance from the FDA for Phase I/II trials in multiple other cancers.  The Company has also conducted a Phase I/II trial with DCVax for metastatic ovarian cancer together with the University of Pennsylvania. 

Disclaimer

Statements made in this news release that are not historical facts, including statements concerning future treatment of patients using DCVax and future clinical trials, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Words such as "expect," "believe," "intend," "plan," "continue," "may," "will," "anticipate," and similar expressions are intended to identify forward-looking statements.  Actual results may differ materially from those projected in any forward-looking statement.  Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated, such as the Company's ability to raise additional capital, risks related to the Company's ability to enroll patients in its clinical trials and complete the trials on a timely basis, the uncertainty of the clinical trials process, uncertainties about the timely performance of third parties, and whether the Company's products will demonstrate safety and efficacy.  Additional information on these and other factors, including Risk Factors, which could affect the Company's results, is included in its Securities and Exchange Commission ("SEC") filings.  Finally, there may be other factors not mentioned above or included in the Company's SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement.  You should not place undue reliance on any
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Paragon Bioservices Wins CMO Leadership Awards for Third Consecutive Year
2. Rancho BioSciences Partners with OmicSoft for Manual Data Curation
3. Regado Biosciences, Inc. Announces Exercise of Over-Allotment Option
4. Fisher BioServices Intensifies Commitment for Cell Therapy Companies in Clinical Trials and Approaching Commercialization
5. Sanguine BioSciences Signs Agreements with More than 200 Partners to Enable Efficient Personalized Medicine Research
6. Rancho BioSciences Launches Rancho tranSMART Hosted for Clinical and Genomic Data Storage and Analysis
7. Acquisitions, Clinical Trial Results, Date Extensions and Financial Results - Research Report on Endo, Astex, Auxilium, Accuray, and BioScrip
8. Indigo BioSystems, Inc. Ranks in the 2013 Inc. 500
9. 5000 for America's Fastest Growing Companies
10. Former Life Technologies and BD Biosciences Executive John L. "Kip" Miller Joins Solulinks Board of Directors
11. Physician Familiarity With Biosimilars Has Increased Significantly Over The Past Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... group leader Yung-Eun Sung has announced that they ... nitrogen-doped graphenes which can be applied as high ... Yung-Eun Sung is both a group leader at ... Basic Science* (IBS) and a professor at the ... significance with regards to the development of relative ...
(Date:7/24/2014)... -- Research and Markets has announced the ... report to their offering.  ... in vitro growth of plant or animal cells for ... production. Cell culture is a crucial step in tissue ... culture consumables are necessary for the in vitro production ...
(Date:7/24/2014)... July 24, 2014  CorMedix Inc. (NYSE MKT: ... commercializing therapeutic products for the prevention and treatment ... of notice on July 18, 2014 from the ... accepted the CorMedix plan to regain compliance with ... result, the NYSE-MKT is continuing the Company,s listing ...
(Date:7/24/2014)... N.J. , July 24, 2014 ... provider of regulatory and ethical review services for ... Alliance Biosciences. Formerly a division of ... was the leading biosafety and biosecurity consulting firm ... With this addition, WCG,s biosafety division – WCG ...
Breaking Biology Technology:Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3
... May 21 Martek Biosciences,Corporation (Nasdaq: MATK ) ... UBS Global Generic and Specialty Pharmaceuticals Conference in,London. The ... at the Waldorf,Hilton, Aldwych, London. Steve Dubin, CEO will ... EDT (2:00 p.m. London Time)., Interested parties may ...
... Still River Systems announces,the successful development and operation ... of the development of its Monarch250(TM) proton,therapy system. ... conclusively,demonstrates that cyclotrons at this high field strength ... By increasing the operating,magnetic field, Still River Systems ...
... N.J., May 21 Aton Pharma, Inc., a ... signed a,marketing and distribution agreement with PharmaLink Asia ... into several countries in Asia and,Australia., "This ... we execute,our mission to expand access to our ...
Cached Biology Technology:Still River Systems Announces Operation of the World's Highest Magnetic Field Cyclotron 2Aton Pharma Announces Distribution Partnership in the Asia Pacific Region 2
(Date:7/23/2014)... , July 24, 2014 Pfenex Inc. (NYSE ... offering of 8,333,333 shares of its common stock at a ... Pfenex has granted the underwriters a 30-day option to purchase ... initial public offering price. The shares are expected to begin ... the symbol "PFNX". William Blair & ...
(Date:7/23/2014)... or neglected early in life are at risk ... In a new study, scientists have found that ... has implications for children,s long-term development. Previous studies ... and genetics interacted with that child,s experiences in ... In the new study, researchers were able to ...
(Date:7/23/2014)... crow and the pitcher, a thirsty bird happens upon a ... it, he finds the water level out of his reach. ... drops pebbles into it one at a time ... his fill. , Highlighting the value of ingenuity, the fable ... brute force. It also characterizes crows as pretty resourceful problem ...
Breaking Biology News(10 mins):Pfenex Inc. Announces Pricing Of Initial Public Offering 2Stress tied to change in children's gene expression related to emotion regulation, physical health 2Stress tied to change in children's gene expression related to emotion regulation, physical health 3Smarter than a first-grader? 2Smarter than a first-grader? 3Smarter than a first-grader? 4
... Researchers have identified a gene that appears to increase a ... type of Alzheimer,s disease. The research will be presented as ... of Neurology,s 62nd Annual Meeting in Toronto, April 10 ... six. "Only recently have common variants in genes ...
... who co-piloted the historic 1960 deep-sea voyage of the Trieste, will ... on at 10 a.m. April 15 at the U.S. Navy Museum ... to have visited the Challenger Deep the deepest part of ... navigating the bathyscaphe (deep submergence vehicle) Trieste 35,810 feet down to ...
... 13, 2010 -- Two chemists at The Scripps Research Institute have ... that turns itself on or off as it detects metallic ions ... the April 19, 2010 issue of the International Edition of the ... tool for controlling tiny reactions in the test tube, and it ...
Cached Biology News:New gene associated with increased risk of Alzheimer's disease 2New nano-tool synthesized at Scripps Research Institute 2
... Visualizer DX's sensitivity of DNA detection has been ... in an agarose gel can be detected > ... can be purified by organic solvent extraction or ... kits worked well.) DNA excised from agarose ...
Mouse monoclonal antibody raised against a full length recombinant CSNK2A2. NCBI Entrez Gene ID = CSNK2A2...
... Small space saving design - ideal for personal ... models: , - 3D gyratory action SSM3 , ... speed control and built-in timer , Optional tier system ... ideal where gentle mixing is required, either on the ...
... The TargeTron(TM) Gene Knockout System provides optimized ... specific disruption of bacterial genes by insertion ... the retrohoming ability of group II introns ... re-target the TargeTron group II intron for ...
Biology Products: